首页> Advances in therapy> Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis.

Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis.

导出 OA

翻译打印收藏纠错

第一作者： Robert P,Finger

第一单位： Department of Ophthalmology, University of Bonn, Bonn, Germany. robert.finger@ukbonn.de.

作者： Robert P,Finger ^[1] ; Natalie,Dennis ^[2] ; Rita,Freitas ^[3] ; Arthur,Quenéchdu ^[4] ; Andreas,Clemens ^[5] ; Helene,Karcher ^[6] ; Eric H,Souied ^[7]

作者单位： Department of Ophthalmology, University of Bonn, Bonn, Germany. robert.finger@ukbonn.de. ^[1] Health Economics and Market Access, Amaris, Paris, France. ^[2] Novartis Farma-Produtos Farmacêuticos S.A., Porto Salvo, Portugal. ^[3] Amaris, Health Economics and Market Access, Montréal, Canada. ^[4] Novartis Pharma AG, Basel, Switzerland.;Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center Freiburg University, University of Freiburg, Freiburg, Germany. ^[5] Novartis Pharma AG, Basel, Switzerland. ^[6] Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, University Paris Est Créteil, Créteil, France.;Clinical Research Center, GRC Macula, Biological Resources Center, Centre Hospitalier Intercommunal de Créteil, Créteil, France. ^[7]

关键词 Anti-VEGF Brolucizumab NMA Neovascular age-related macular degeneration Network meta-analysis nAMD